Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care professional injects into fat under the skin. These subcutaneous medications include ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDPFirst novel mechanism of action for CIDP treatment in more than 30 yearsCHMP positive opinion based on ADHERE data, the largest ...

Using the latest data and perspectives, an international expert panel releases updated recommendations for optimal insulin ...

The injection takes just 3-5 min to administer ... This randomised, open-label phase 3 clinical trial compared subcutaneous and IV nivolumab in patients with previously treated advanced or ...

Amsterdam, the Netherlands Tuesday, April 29, 2025, 10:00 Hrs [IST] ...

Subcutaneous injections of Darbe have been used to effectively treat anemia of prematurity and boost red blood cell ...

It’s common to feel nervous (and maybe even spaced out) when your doctor demonstrates how to inject yourself with ...

This innovative rollout makes England the first country in Europe to adopt the approach at scale. NHS officials expect the treatment to be made available to around 1,200 eligible patients per month.